All In MedTech

Device Trial Radar · NCT03067480

Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients

Comparison of 3 Versus 6-Month Use of Professional Continuous Glucose Monitoring in the Treatment of Poorly Controlled, Non-Insulin Using T2DM Patients in a Primary Care Setting

Last checked: Nov 19, 2026Latest source record: Jan 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

12

Actual

Start

Jun 6, 2017

Primary completion

Sep 30, 2019

Study completion Sep 30, 2019

Sponsor

Lead sponsor
East Tennessee State UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Medtronic
First posted
Mar 1, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine whether 3-month versus 6-month professional CGM utilization improves time spent in target range of 70-140mg/dl in patients with poorly controlled T2DM not treated with insulin.

Conditions

  • T2DM (Type 2 Diabetes Mellitus)
  • Continuous Glucose Monitoring

Interventions

  • iPro2 Professional CGMDevice

    Professional CGM measures interstitial glucose every 5 minutes via a glucose-oxidase-impregnated membrane during a 3 day period. The patient wearing professional CGM is blinded to the repeated measurements and the data is stored for retrospective analysis.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time Spent in Target RangeTime frame: 6 Months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • East Tennessee State University

    Johnson City, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.